SEARCH BY

Issuer directory Issuer directory
KEYWORDS
COMPANIES / ISIN
TYPE OF INFORMATION
INDUSTRY

Start search  ADVANCED SEARCH

COMPARTMENTS / INDICES

France
America
Asia
Oceania
Africa
Europe

AEX NEWS

FEEDS

My RSS My Google Microsoft Live My Yahoo

COMPANY SEARCH RESULT

GALAPAGOS: Click to view the issuer\'s details

Last update : 21/08/2018  >View issuer details

2020.09.18 | 22:01 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Galapagos increases share capital through subscription right exercises - HTML (w)

2020.09.18 | 22:01 | Permanent Information Releases / General Company News

Dutch version HTML (w) Mail

puce Galapagos verhoogt kapitaal door uitoefening van inschrijvingsrechten - HTML (w)

2020.09.11 | 04:30 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Primary endpoint achieved with ziritaxestat  in NOVESA trial in systemic sclerosis patients - HTML (w)

2020.09.11 | 04:30 | Permanent Information Releases / General Company News

Dutch version HTML (w) Mail

puce Primair eindpunt bereikt met ziritaxestat  in NOVESA-studie bij patiënten met systemische sclerose - HTML (w)

2020.08.12 | 22:01 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Scipher Medicine and Galapagos sign collaboration in inflammatory bowel disease - HTML (w)

2020.08.12 | 22:01 | Permanent Information Releases / General Company News

Dutch version HTML (w) Mail

puce Scipher Medicine en Galapagos ondertekenen samenwerkingsovereenkomst voor inflammatoire darmziekten   - HTML (w)

2020.08.06 | 22:01 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce Galapagos reports solid H1 2020 progress - HTML (w)

2020.08.06 | 22:01 | Permanent Information Releases / General Company News

Dutch version HTML (w) Mail

puce  Galapagos rapporteert sterke voortgang in H1 2020 - HTML (w)

2020.06.05 | 22:01 | Permanent Information Releases / General Company News

English version HTML (w) Mail

puce NEW ANALYSES OF PHASE 2 EQUATOR CLINICAL PROGRAM SUPPORT DURABLE EFFICACY OF FILGOTINIB IN PSORIATIC ARTHRITIS - HTML (w)

Pages : 1 - 2 - 3 - 4 - 5 - 6 - 7 - 8 - 9 - 10 / Doc nb : 258